Thieblemont C, Karimi YH, Ghesquieres H, Cheah CY, et al. Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial. Leukemia 2024 Sep 25. doi: 10.1038/s41375-024-02410.
PMID: 39322711